Skip to content

Triptorelin (Trelstar, Decapeptyl) clinical trials: 58 trials

Page 1 of 2

Read 58 Triptorelin (Trelstar, Decapeptyl) clinical trials with posted results or linked papers with results in PepBank.

  1. Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    NCT00066690 · Phase 3 · Completed

    Posted results

  2. Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    NCT00066703 · Phase 3 · Completed

    Posted results

  3. Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

    NCT00567580 · Phase 3 · Status unknown

    Posted results

  4. Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

    NCT00936390 · Phase 3 · Completed

    Posted results

  5. Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

    NCT01020448 · Phase 3 · Completed

    Posted results

  6. Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis

    NCT03232281 · Phase 3 · Completed

    Posted results

  7. A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)

    NCT00725491 · Phase 3 · Completed

    Posted results

  8. Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

    NCT01546987 · Phase 3 · Completed

    Posted results

  9. A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

    NCT01753297 · Phase 4 · Completed

    Posted results

  10. Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

    NCT05590793 · Phase 3 · Completed

    Posted results

  11. Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

    NCT05458856 · Phase 3 · Completed

    Posted results

  12. Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer

    NCT01715129 · Phase 3 · Completed

    Posted results

  13. Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer

    NCT01656161 · Phase 3 · Completed

    Posted results

  14. Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

    NCT01607203 · Phase 4 · Completed

    Posted results

  15. Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

    NCT00751790 · Phase 3 · Completed

    Posted results

  16. Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

    NCT01161563 · Phase 4 · Completed

    Posted results

  17. Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

    NCT04537078 · Phase 3 · Completed

    Posted results

  18. Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

    NCT00659373 · Phase 3 · Completed

    Posted results

  19. A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.

    NCT05029622 · Phase 3 · Completed

    Posted results

  20. Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation

    NCT02342197 · Phase 3 · Completed

    Posted results

  21. Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

    NCT01467882 · Phase 3 · Completed

    Posted results

  22. Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty

    NCT00564850 · Phase 3 · Completed

    Posted results

  23. Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study

    NCT00909844 · Phase 3 · Completed

    Posted results

  24. Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.

    NCT04736602 · Phase 3 · Completed

    Posted results

  25. Premenopausal Endocrine Responsive Chemotherapy Trial

    NCT00066807 · Phase 3 · Terminated

    Posted results

  26. GP Extended Action Triptorelin

    NCT01673984 · Phase 4 · Terminated

    Posted results

  27. Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures

    NCT02048891 · Phase 4 · Completed

    Posted results

  28. Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

    NCT05781217 · Phase 3 · Recruiting

    Linked paper with results

  29. Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

    NCT00311636 · Phase 3 · Completed

    Linked paper with results

  30. Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

    NCT04008966 · Phase 4 · Completed

    Linked paper with results

  31. Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP

    NCT06487143 · Phase 4 · Not yet recruiting

    Linked paper with results

  32. Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure

    NCT01160315 · Phase 2/3 · Completed

    Linked paper with results

  33. Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support

    NCT05286554 · Phase 4 · Completed

    Linked paper with results

  34. Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

    NCT02825290 · Phase 4 · Status unknown

    Linked paper with results

  35. A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

    NCT03809000 · Phase 2 · Active, not recruiting

    Posted results

  36. Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg

    NCT01257425 · Phase 2 · Completed

    Posted results

  37. The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    NCT01790126 · Phase 2 · Completed

    Posted results

  38. Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

    NCT02168062 · Phase 2 · Terminated

    Posted results

  39. TRial on the Endocrine Activity of Neoadjuvant Degarelix

    NCT02005887 · Phase 2 · Completed

    Posted results

  40. Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

    NCT00090844 · Phase 2 · Terminated

    Posted results

  41. Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer

    NCT01374087 · Phase 2 · Terminated

    Posted results

  42. Triptorelin for Ovary Protection in Childhood Onset Lupus

    NCT00124514 · Phase 2 · Completed

    Posted results

  43. Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

    NCT00194792 · Phase 2 · Terminated

    Posted results

  44. Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

    NCT02278185 · Phase 2 · Completed

    Posted results

  45. Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients

    NCT06225284 · Phase 2 · Recruiting

    Linked paper with results

  46. Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

    NCT05701007 · Phase not stated · Completed

    Posted results

  47. Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02

    NCT00975676 · Not applicable · Completed

    Posted results

  48. Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)

    NCT00702520 · Phase not stated · Completed

    Posted results

  49. GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

    NCT00516490 · Not applicable · Completed

    Linked paper with results

  50. Luteal Phase Support In IVF Women Using GnRH Agonist

    NCT04174378 · Phase not stated · Completed

    Linked paper with results

How PepBank reports evidence